The M-current activator retigabine both blocks the hyperexcitability and improves motor neuron survival in vitro when tested in SOD1 mutant ALS patient iPS cell-derived motoneurons in culture [91]. Here, SOD1 is linked to amyotrophic lateral sclerosis.